<p><b></b> Late Afternoon<p/><b>Me:</b> I have to study this shit<p/><b>Brain:</b> meh, you're tired now<p/><b>Me:</b> Brain, no. I have to pass this fucking Test!<p/><b>Brain:</b> I said tired!<p/><b></b> Later in the night<p/><b>Me:</b> ok, I think I can go to sleep now<p/><b>Brain:</b> nope, I'm good<p/><b>Me:</b> Brain please, I need rest!<p/><b>Brain:</b> Nah, remember how embarrassing that day 4 years ago was?<p/><b>Me:</b> Brain, no, let me sleep!<p/><b>Brain:</b> No. Fuck you.<p/></p>
Blocking Key Enzyme Halts Parkinson’s Symptoms in Mice
Researchers have gleaned two important new clues in the fight against Parkinson’s disease that could point toward a more effective therapy for the disease, and a way of better monitoring its course: blocking an enzyme called c-Abl prevents the disease in specially bred mice, and that a chemical tag on a second protein may signal the disorder’s presence and progression.
“There were indications that c-Abl activity leads to Parkinson’s disease, and our experiments show there is indeed a connection,” says Ted Dawson, M.D., PhD, professor of neurology and director of the Institute for Cell Engineering at the Johns Hopkins University School of Medicine. “There is already a Food and Drug Administration-approved c-Abl inhibiting drug in use for leukemia,” he adds, “so we’re interested in whether it could be used safely against Parkinson’s disease or as a starting point to develop other treatments.”
This work was supported by grants from the National Institute of Neurological Disorders and Stroke (grant numbers NS38377 and NS082205), the JPB Foundation, and a Parkinson’s Disease Foundation Summer Student Fellowship (number PDF-SFW-1572). Dawson is the Leonard and Madlyn Abramson Professor of Neurodegenerative Diseases. The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through their direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine.
Raise your voice in support of expanding federal funding for life-saving medical research by joining the AAMC’s advocacy community.
Study Shows That “Male” And “Female” Brains Are A Myth
A recent study proves that “all male” and “all female” brains are rare and that most people are in the middle.
Awareness about gender fluidity has been increasing in recent years as sexuality and identity are being questioned and the current wave of feminism challenges traditional gender roles and the supposed abilities of each sex.
A recent study published in the Proceedings of the National Academy of Sciencesfurther challenged the assumed differences between the sexes by studying the brains of 1,400 males and females to determine if there really are distinct differences. Find out what we discovered below:
A human brain has around 86 billion neurons, and the communication between these neurons are constant. The sheer scale of these interactions mean a computer (an EEG) can register this electrical activity, with different frequencies indicating different mental states.
Knowing more than one language
keeps your brain young and forces
it to be more flexible. Studies show
degenerative disorders like
Alzheimer’s and dementia are
delayed by up to 5 years
for bilingual people. Source